Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesBreastARRS: Breast RT doesn't impact presence of breast arterial calcificationsServiceIMV: PET/CT service contracts are a key aspect of system ownershipWomens ImagingARRS: Get involved with breast health advocacyCTARRS: The state of lung imagingWomens ImagingARRS: Most women under 40 have no imaging before breast cancer diagnosis